Organogenesis Holdings (ORGO) Total Liabilities (2015 - 2026)
Organogenesis Holdings (ORGO) recorded quarterly Total Liabilities of $138.6 million in Q1 2026, down 15.88% quarter-over-quarter from $164.8 million in Q4 2025, and up 39.59% on a YoY basis from $99.3 million in Q1 2025.
Organogenesis Holdings (ORGO) Total Liabilities (2015 - 2026) Analysis & Trends
Organogenesis Holdings' Total Liabilities history runs 12 years deep, the most recent figure standing at $138.6 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 39.59% year-over-year to $138.6 million; the TTM figure through Mar 2026 stood at $138.6 million (up 39.59% YoY), while the FY2025 annual figure was $164.8 million, up 46.41% from the prior year.
- Total Liabilities was $138.6 million for Q1 2026 at Organogenesis Holdings, down from $164.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $202.0 million in Q2 2022 to a low of $99.3 million in Q1 2025.
- Historically, Total Liabilities has averaged $163.3 million across 5 years, with a median of $179.7 million in 2024.
- Biggest YoY gain for Total Liabilities was 46.41% in 2025; the steepest drop was 44.96% in 2025.
- A 5-year view of Total Liabilities shows it stood at $183.7 million in 2022, then fell by 1.27% to $181.4 million in 2023, then tumbled by 37.93% to $112.6 million in 2024, then soared by 46.41% to $164.8 million in 2025, then declined by 15.88% to $138.6 million in 2026.
- The last three Total Liabilities figures came in at $138.6 million (Q1 2026), $164.8 million (Q4 2025), and $123.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 31.81 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 11.92 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 813.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 148.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.50 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.72 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.51 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.13 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.82 Bn |
| 10 | Organogenesis Holdings | 304.80 Mn | 212.70 Mn | 11.46 Mn | 138.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 138.65 Mn |
| Dec 31, 2025 | 164.81 Mn |
| Sep 30, 2025 | 123.85 Mn |
| Jun 30, 2025 | 99.91 Mn |
| Mar 31, 2025 | 99.33 Mn |
| Dec 31, 2024 | 112.57 Mn |
| Sep 30, 2024 | 167.75 Mn |
| Jun 30, 2024 | 179.66 Mn |
| Mar 31, 2024 | 180.45 Mn |
| Dec 31, 2023 | 181.36 Mn |
| Sep 30, 2023 | 185.78 Mn |
| Jun 30, 2023 | 179.03 Mn |
| Mar 31, 2023 | 182.41 Mn |
| Dec 31, 2022 | 183.69 Mn |
| Sep 30, 2022 | 200.94 Mn |
| Jun 30, 2022 | 201.97 Mn |
| Mar 31, 2022 | 194.74 Mn |
| Dec 31, 2021 | 201.92 Mn |
| Sep 30, 2021 | 181.25 Mn |
| Jun 30, 2021 | 176.64 Mn |